Welcome to our dedicated page for Bruker Corporation news (Ticker: $BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker Corporation stock.
Bruker Corporation (symbol: BRKR) stands as a global leader in analytical instrumentation. With over fifty years of innovation, Bruker aims to provide top-tier technological solutions for various analytical tasks. Headquartered in Massachusetts, USA, Bruker employs more than 6,500 individuals across 90 locations worldwide.
The company's operations are categorized into four main segments:
- BSI BioSpin: Specializes in magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
- BSI CALID: Focuses on mass spectrometry, chromatography, molecular spectroscopy, and in vitro diagnostics.
- BSI Nano: Offers solutions in X-ray diffraction, elemental analysis, atomic force microscopy, and surface and dimensional metrology.
- Bruker Energy & Supercon Technologies (BEST): Provides superconducting materials and devices for energy, science, and healthcare sectors.
Bruker demonstrates a strong commitment to research and development, continuously expanding its suite of products and maintaining a robust installed base globally. The company’s dedication to quality and reliability is reflected in its significant presence in the Asia Pacific region, which accounts for the largest share of its revenue.
Recent achievements include advancements in mass spectrometry and collaborations with leading pharmaceutical and biotechnology companies. Bruker's technologies are vital for quality assurance in industrial production processes, supporting customers in ensuring precision and reliability.
Bruker Corporation is not just a manufacturer but a partner in innovation, helping scientists and researchers address complex analytical challenges with integrity and cutting-edge technology.
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has announced the acquisition of Chemspeed Technologies AG, a Swiss provider of automated laboratory R&D and QC workflow solutions. The acquisition accelerates Bruker’s lab automation and digitalization drive, complementing its vendor-agnostic platform SciY™. Chemspeed generated revenues greater than $50 million in 2023 and was profitable. The transaction is expected to close in the first half of 2024, subject to regulatory reviews.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
-
Rhea-AI Summary
Biognosys, a leader in next-generation proteomics solutions, opens a new CRO facility in Massachusetts to provide high-throughput proteome profiling services for US biopharma customers. The facility will focus on TrueDiscovery® data-independent acquisition (DIA) discovery proteomics services, powered by the Bruker timsTOF mass spectrometry platform. The expansion aims to bring cutting-edge proteomics closer to US customers, enabling them to leverage the potential of proteomics for therapeutic discoveries and drug development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
-
Rhea-AI Summary
Bruker (BRKR) acquires Canadian company Tornado Spectral Systems Inc., specializing in process Raman instruments for pharma and biotech quality control. Tornado's patented technologies and product line will enhance Bruker's biopharma PAT portfolio. Financial details were not disclosed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
Rhea-AI Summary
Bruker Corporation (BRKR) to participate in 42nd annual J.P. Morgan Healthcare Conference, with top executives presenting on January 8th, 2024. Live webcast and replay available on the Company's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) Acquires Nion, a Leader in High-End STEM Technology for Materials Science Research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) installs a 1.2 Gigahertz (GHz) NMR system at The Ohio State University, enabling advanced life science and materials research. The system will be used for high-resolution liquid and solid-state NMR experiments to study advanced materials and biological molecules, with the goal of advancing the understanding of the underlying mechanisms of diseases such as cancer, cardiovascular disease, viral infections, or Alzheimer’s disease.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
Rhea-AI Summary
Accelerate Diagnostics, Inc. (AXDX) collaborates with Bruker Corporation (BRKR) to bring rapid, automated microbial identification directly from positive blood culture samples. The agreement validates the use of Accelerate Diagnostics' Arc™ system with Bruker's MALDI Biotyper® sirius instruments and Sepsityper® software for registration in the US and EMEA markets. The Arc™ system enables on-demand processing of samples without the need for overnight culture incubation, reducing wait time for identification results. It competes with molecular positive blood culture identification solutions, offering potential cost savings and reduced likelihood of false positive results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.58%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) approves quarterly cash dividend of $0.05 per share, to be paid on December 15, 2023, to stockholders of record as of December 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.42%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, will present on Tuesday, November 14, 2022, at 8:30 AM GMT. A live webcast will be available on the Investor Relations section of the Company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
Rhea-AI Summary
Bruker Corporation reports Q3 2023 revenues of $742.8 million, up 16.3% YoY. Organic revenue growth is 10.9% YoY. Q3 2023 GAAP EPS is $0.60, non-GAAP EPS is $0.74, up 12.1% YoY. FY 2023 revenue guidance increased to $2.88-$2.91 billion, implying reported revenue growth of 14%-15% YoY and organic revenue growth of 11.5%-12.5% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
FAQ
What does Bruker Corporation specialize in?
Bruker Corporation specializes in analytical instrumentation, offering solutions in magnetic resonance, mass spectrometry, X-ray analysis, and superconducting technologies.
How is Bruker Corporation structured?
Bruker operates in four main segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST).
Where does Bruker generate most of its revenue?
The majority of Bruker's revenue is generated from the Asia Pacific region.
How many employees does Bruker Corporation have?
Bruker Corporation employs over 6,500 people globally.
What industries does Bruker serve?
Bruker serves the life sciences, pharmaceutical, biotechnology, and industrial production sectors.
What recent advancements has Bruker made?
Bruker has made significant advancements in mass spectrometry and has formed key partnerships with leading pharmaceutical and biotechnology firms.
What is BSI BioSpin known for?
BSI BioSpin is known for its magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
Why are Bruker's technologies important in industrial production?
Bruker's instruments ensure quality and process reliability, which are critical for precision and performance in industrial production.
What is the BEST segment of Bruker Corporation?
BEST, or Bruker Energy & Supercon Technologies, provides superconducting materials and devices for the energy, science, and healthcare sectors.
How does Bruker Corporation contribute to scientific research?
Bruker develops state-of-the-art technologies that assist scientists and researchers in addressing complex analytical questions with precision.
Bruker Corporation
Nasdaq:BRKR
BRKR Rankings
BRKR Stock Data
9.77B
89.37M
34.66%
81.89%
2.41%
Analytical Laboratory Instrument Manufacturing
Manufacturing
United States of America
BILLERICA